Money Talks

An Interactive Interview with a Venture Capitalist on the Ins and Outs of Securing Funding for Life Sciences Companies

November 10, 2020 9:30am

Bernard P. Cooney, III
Senior Partner, Capital Formation
Flagship Pioneering (Cambridge, MA)

Interviewed by:

Jennifer K. Gregory
Assistant General Patent Counsel - IP Transactions
Eli Lilly and Company (Indianapolis, IN)

Partnering with an investment firm to secure funding is an essential and valuable tool to facilitate business expansion and accelerated growth for your life sciences organization. While private equity firms can deliver tactical financial backing and business alliance, venture capital funds can provide a significant capital enhancement for startups. During this interview, our experts will provide insights on topics including:

  • Identifying optimal timing in a life sciences company’s lifecycle to partner with a PE fund versus a VC fund
  • Learning how to assess your portfolio while making it desirable for institutional investors
  • Understanding the factors impacting VC investment decisions and qualities VCs look for from their IP counsel
  • Recognizing capital structure and governance considerations
  • Considering alternative or complimentary sources of funding, e.g. structured and venture lenders, royalty monetization, or intellectual property linked funding